# Dermata Therapeutics, Inc.: Form 8-K, filed Aug 3, 2023

- Company: [Dermata Therapeutics, Inc.](/companies/drma.md) (CIK 1853816)
- Form: 8-K
- Filed: 2023-08-03
- Accepted by EDGAR: Aug 3, 2023, 16:31 ET
- Period: 2023-07-28
- Accession: 0001654954-23-010092
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1853816/000165495423010092/drma_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1853816/000165495423010092/

## Items reported

- Item 4.01: Change of auditor
- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1853816/000165495423010092/drma_8k.htm

Filed Aug 3, 2023.
Source: SEC EDGAR, the filing index for accession 0001654954-23-010092. Last ingested by Listed: Nov 11, 2026, 00:26 ET. No prices; not investment advice.
